Corticosteroid-sparing effect of azelastine in the management of bronchial asthma.


The objective of this double-blind trial was to evaluate the corticosteroid-sparing effect of azelastine in patients with chronic bronchial asthma. A total of 193 subjects received either 6 mg of azelastine twice per day or placebo (in a 2:1 ratio) in combination with beclomethasone dipropionate (6 to 16 inhalations per day). The number of daily inhalations… (More)


Cite this paper

@article{Busse1996CorticosteroidsparingEO, title={Corticosteroid-sparing effect of azelastine in the management of bronchial asthma.}, author={William W. Busse and Erin Middleton and William W Storms and Rainer Dockhorn and T J Chu and Jamie Grossman and John M Weiler and Edwin A Bronsky and Lyndon E Mansfield and Taison D Bell and Glyn R Hemsworth and James L. Perhach and Thomas A D'Eletto and Aniruddha Dam}, journal={American journal of respiratory and critical care medicine}, year={1996}, volume={153 1}, pages={122-7} }